E³ - Advanced Course: Reporting and Data Systems (RADS): from Head to Toe

E³ 419 - Can reporting and data Systems (RADS) improve bone assessment in clinical practice?

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Joan C. Vilanova, Girona / ES

2
Pitfalls in assessing musculoskeletal tumours

Pitfalls in assessing musculoskeletal tumours

20:00Mark D. Murphey, Olney / US

3
Metastasis-reporting and data systems for prostate cancer (MET-RADS-P): standardising whole body MRI assessment of bone metastases

Metastasis-reporting and data systems for prostate cancer (MET-RADS-P): standardising whole body MRI assessment of bone metastases

20:00Anwar R. Padhani, Northwood / UK

4
Myeloma response assessment and diagnosis systems (MY-RADS): standardising whole-body MRI assessment of multiple myeloma

Myeloma response assessment and diagnosis systems (MY-RADS): standardising whole-body MRI assessment of multiple myeloma

20:00Frédéric Lecouvet, Brussels / BE

5
Case-based panel discussion: Is there value in -reporting and data systems (RADS) for musculoskeletal radiology?

Case-based panel discussion: Is there value in -reporting and data systems (RADS) for musculoskeletal radiology?

25:00Joan C. Vilanova, Girona / ES

5 min
Chairperson's introduction
Joan C. Vilanova, Girona / Spain
20 min
Pitfalls in assessing musculoskeletal tumours
Mark D. Murphey, Olney / United States
  1. To learn about three scenarios which can create pitfalls in imaging of musculoskeletal tumours and techniques to avoid these potential diagnostic mischaracterisations including: cyst versus myxoid neoplasm, myositis ossificans, haematoma versus haemorrhagic neoplasm
  2. To appreciate the ability to differentiate cystic lesions such as ganglia, bursa and synovial cysts from myxoid neoplasms, particularly myxoid liposarcoma and myxofibrosarcoma.
  3. To understand the cause of imaging misinterpretation of myositis ossificans as an infiltrative neoplasm.
  4. To recognise the distinguishing imaging features between haematoma from haemorrhagic neoplasm with obvious clinical and medico-legal implications, if delay in diagnosis or misdiagnosis ensues.
20 min
Metastasis-reporting and data systems for prostate cancer (MET-RADS-P): standardising whole body MRI assessment of bone metastases
Anwar R. Padhani, Northwood / United Kingdom
  1. To understand the rationale for standardised assessment of prostate bone metastases in the PSMA era.
  2. To learn about MET-RAD-P criteria for assessing bone metastases and response to therapy.
  3. To appreciate the strengths and limitations of MET-RAD-P in real-world practice.
20 min
Myeloma response assessment and diagnosis systems (MY-RADS): standardising whole-body MRI assessment of multiple myeloma
Frédéric Lecouvet, Brussels / Belgium
  1. To learn about MY-RADS for standardised assessment of multiple myeloma.
  2. To learn how to apply MY-RADS for treatment response evaluation.
  3. To appreciate the challenges of applying MY-RADS for clinical evaluation.
25 min
Case-based panel discussion: Is there value in -reporting and data systems (RADS) for musculoskeletal radiology?
Joan C. Vilanova, Girona / Spain

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.